Polarean Imaging (LSE:POLX) Debt-to-Equity : 0.02 (As of Jun. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Polarean Imaging Debt-to-Equity?

Polarean Imaging's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2023 was £0.11 Mil. Polarean Imaging's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2023 was £0.12 Mil. Polarean Imaging's Total Stockholders Equity for the quarter that ended in Jun. 2023 was £9.81 Mil. Polarean Imaging's debt to equity for the quarter that ended in Jun. 2023 was 0.02.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Polarean Imaging's Debt-to-Equity or its related term are showing as below:

LSE:POLX' s Debt-to-Equity Range Over the Past 10 Years
Min: -0.18 Med: 0.02 Max: 0.32
Current: 0.02

During the past 7 years, the highest Debt-to-Equity Ratio of Polarean Imaging was 0.32. The lowest was -0.18. And the median was 0.02.

LSE:POLX's Debt-to-Equity is ranked better than
91.51% of 707 companies
in the Medical Devices & Instruments industry
Industry Median: 0.21 vs LSE:POLX: 0.02

Polarean Imaging Debt-to-Equity Historical Data

The historical data trend for Polarean Imaging's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Polarean Imaging Debt-to-Equity Chart

Polarean Imaging Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Debt-to-Equity

Get a 7-Day Free Trial

0.03

0.02

Polarean Imaging Semi-Annual Data
	Dec16	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Debt-to-Equity	Get a 7-Day Free Trial								-	0.02	0.02	0.02	0.02

Competitive Comparison of Polarean Imaging's Debt-to-Equity

For the Medical Devices subindustry, Polarean Imaging's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Polarean Imaging's Debt-to-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Polarean Imaging's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Polarean Imaging's Debt-to-Equity falls into.

Polarean Imaging Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Polarean Imaging's Debt to Equity Ratio for the fiscal year that ended in Dec. 2022 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.117	+	0.178)	/	15.849
	=	0.02

Polarean Imaging's Debt to Equity Ratio for the quarter that ended in Jun. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.109	+	0.117)	/	9.814
	=	0.02

Polarean Imaging (LSE:POLX) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Polarean Imaging Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Polarean Imaging's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Polarean Imaging (LSE:POLX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Polarean Imaging PLC (LSE:POLX) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

PLLWF:USA 8ZF:Germany

Address

27-28 Eastcastle Street, London, GBR, W1W 8DH

Website

https://www.polarean.com

Polarean Imaging PLC designs and manufactures medical drug-device combination companies operating in the high-resolution medical imaging market. Its only operating segment being the development and commercialization of gas polariser devices and ancillary instruments. Geographically, it derives most of the revenue from the United States of America and also has a presence in Canada and the United Kingdom. The company generates revenue from products and services such as Polarisers, Parts and Upgrades, Service and other revenue. Its product portfolio includes 9820 129Xe Hyperpolarizer, 9800 129Xe Hyperpolarizer, Polarean 3777 129Xe Hyperpolarizer Upgrade Module, Polarean 2881 Polarization Measurement Station, and others.

Polarean Imaging (LSE:POLX) Headlines

No Headlines